333 related articles for article (PubMed ID: 10741139)
21. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
[TBL] [Abstract][Full Text] [Related]
22. Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology.
Chott A; Haedicke W; Mosberger I; Födinger M; Winkler K; Mannhalter C; Müller-Hermelink HK
Am J Pathol; 1998 Nov; 153(5):1483-90. PubMed ID: 9811340
[TBL] [Abstract][Full Text] [Related]
23. Natural killer cell neoplasms.
Liang X; Graham DK
Cancer; 2008 Apr; 112(7):1425-36. PubMed ID: 18286525
[TBL] [Abstract][Full Text] [Related]
24. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas.
Tsang WY; Chan JK; Yip TT; Ng CS; Wong KF; Poon YF; Ma VW
Hum Pathol; 1994 Aug; 25(8):758-65. PubMed ID: 7520016
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma.
Pan ST; Chang WS; Murphy M; Martinez A; Chuang SS
Am J Dermatopathol; 2011 Apr; 33(2):e17-20. PubMed ID: 21252637
[TBL] [Abstract][Full Text] [Related]
26. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype.
Dukers DF; Vermeer MH; Jaspars LH; Sander CA; Flaig MJ; Vos W; Willemze R; Meijer CJ
J Clin Pathol; 2001 Mar; 54(3):224-8. PubMed ID: 11253136
[TBL] [Abstract][Full Text] [Related]
27. Natural killer and natural killer-T cells in psoriasis.
Cameron AL; Kirby B; Fei W; Griffiths CE
Arch Dermatol Res; 2002 Nov; 294(8):363-9. PubMed ID: 12420105
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and management of natural killer-cell malignancies.
Ishida F; Kwong YL
Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
[TBL] [Abstract][Full Text] [Related]
29. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
[TBL] [Abstract][Full Text] [Related]
30. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.
Chan JK; Sin VC; Wong KF; Ng CS; Tsang WY; Chan CH; Cheung MM; Lau WH
Blood; 1997 Jun; 89(12):4501-13. PubMed ID: 9192774
[TBL] [Abstract][Full Text] [Related]
31. [Nasal/nasopharyngeal T/NK-cell lymphomas with evident angiogenic activity].
Zhang HY; Huang GS; Zhu HT; Zhang YQ; Guo Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):317-9. PubMed ID: 12940067
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological analyses of 5 Japanese patients with CD56+ primary cutaneous lymphomas.
Kojima H; Mukai HY; Shinagawa A; Yoshida C; Kamoshita M; Komeno T; Hasegawa Y; Yamashita Y; Mori N; Nagasawa T
Int J Hematol; 2000 Dec; 72(4):477-83. PubMed ID: 11197216
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56- phenotype, and its relation to Epstein-Barr virus: a report of two cases.
Kagami Y; Sobue R; Ito N; Yatabe Y; Taji H; Suzuki R; Seto M; Ogura M; Suchi T; Morishima Y; Nakamura S
Int J Hematol; 1999 Aug; 70(2):105-11. PubMed ID: 10497849
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
[TBL] [Abstract][Full Text] [Related]
36. Three cases of extranodal NK/T-cell lymphoma of the nasal type diagnosed by nasal brush cytology.
Kishimoto K; Kitamura T; Hirayama Y; Tate G; Mitsuya T
Diagn Cytopathol; 2007 Feb; 35(2):125-9. PubMed ID: 17230578
[TBL] [Abstract][Full Text] [Related]
37. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression.
Quintanilla-Martinez L; Franklin JL; Guerrero I; Krenacs L; Naresh KN; Rama-Rao C; Bhatia K; Raffeld M; Magrath IT
Hum Pathol; 1999 Jul; 30(7):849-55. PubMed ID: 10414505
[TBL] [Abstract][Full Text] [Related]
38. Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: implications on cellular origin.
Chiang AK; Srivastava G; Lau PW; Ho FC
Hum Pathol; 1996 Jul; 27(7):701-7. PubMed ID: 8698315
[TBL] [Abstract][Full Text] [Related]
39. Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK.
Child FJ; Mitchell TJ; Whittaker SJ; Calonje E; Spittle M; Crocker J; Russell-Jones R
Br J Dermatol; 2003 Mar; 148(3):507-15. PubMed ID: 12653743
[TBL] [Abstract][Full Text] [Related]
40. [Immunophenotype of nasal T-cell lymphoma].
Eizuru Y; Ueno K
Nihon Rinsho; 1997 Feb; 55(2):400-3. PubMed ID: 9046831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
